🧬 Biotech - buckman · Scour

Personalized CRISPR therapies could soon reach thousands 🧬Genetics

United States : How US intelligence is tackling biotechnology challenge 🕵️Intelligence

intelligenceonline.com

·2d

Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI 🇨🇳Chinese Technology

thenextweb.com·1d

STAT+: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride 🧬Biotechnology

statnews.com·6d

New Gene Therapy Can Restore Hearing in Deaf Kids—And It Comes With an Unexpected Price Tag 💉mRNA Technology

FDA Gives Green Light To the First Gene Therapy For Deafness 💉mRNA Technology

science.slashdot.org·1d

🔬 Training Transformers to solve 95% failure rate of Cancer Trials — Ron Alfa & Daniel Bear, Noetik 🛡️AI Safety

latent.space·6d

Hallucinogenics are illegal under federal law but that isn’t stopping the FDA from fast tracking 3 psychedelic drugs to treat mental health 🧠Nootropics

·2d

Eli Lilly is buying cancer biotech Kelonia Therapeutics for more than $2 billion 🧬Biotechnology

Dallas’ Great American Food Chain Completes Merger With Phoenix’s GreenMatter Biotech 🏗️DFW Development

s24806.pcdn.co·1d

Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine 💉mRNA Technology

arstechnica.com·2d·Hacker News, Hacker News

Why clinical trials are broken & how to fix them: a reading list 📋Patent Law

lesswrong.com·6d

The COVID Reckoning Doesn't Go Far Enough 🪟Overton Window

Biotech-led boom as 8 China firms flock to Hong Kong’s thriving stock market 🇨🇳Chinese Technology

·4d·r/SCMPauto

Exclusive | Eli Lilly Nears Deal for Cancer Biotech 🧬Biotechnology

news.google.com

·6d

Courier Health, which develops an AI-powered biopharma platform for managing the end-to-end patient experience, raised a $50M Series B led by Oak HC/FT (Heather... 🔄AI Workflows

techmeme.com·3d

Exclusive 💰Tokenomics

Daily briefing: Should we worry about AI doomsday? ♾️Systems Thinking

OpenAI launches GPT-Rosalind, an AI model built for drug discovery and life sciences 🧠OpenAI

Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride 🧬Biotechnology

news.google.com

·6d

No more posts from buckman's subscribed feeds.

Scour all 24390 feeds Learn more about Feeds

Log in to enable infinite scrolling